BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2551064)

  • 1. Purification and characterization of plasma protein C inhibitor.
    España F; Berrettini M; Griffin JH
    Thromb Res; 1989 Aug; 55(3):369-84. PubMed ID: 2551064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.
    Meijers JC; Kanters DH; Vlooswijk RA; van Erp HE; Hessing M; Bouma BN
    Biochemistry; 1988 Jun; 27(12):4231-7. PubMed ID: 2844223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
    Radtke KP; Stief TW; Heimburger N
    Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin stimulation of the inhibition of activated protein C and other enzymes by human protein C inhibitor--influence of the molecular weightof heparin and ionic strength.
    Aznar J; España F; Estellés A; Royo M
    Thromb Haemost; 1996 Dec; 76(6):983-8. PubMed ID: 8972021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
    van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
    Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
    España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
    Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
    Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
    Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.
    Ecke S; Geiger M; Resch I; Jerabek I; Sting L; Maier M; Binder BR
    J Biol Chem; 1992 Apr; 267(10):7048-52. PubMed ID: 1313031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
    Shen L; Villoutreix BO; Dahlbäck B
    Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.
    Cronlund AL; Walsh PN
    Biochemistry; 1992 Feb; 31(6):1685-94. PubMed ID: 1737024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor.
    Van Walderveen MC; Berry LR; Chan AK
    J Biochem; 2010 Aug; 148(2):255-60. PubMed ID: 20538715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitronectin modulates glycosaminoglycan dependent reactions of protein C inhibitor.
    Seiffert D; Geiger M; Ecke S; Binder BR
    Thromb Haemost; 1992 Dec; 68(6):657-61. PubMed ID: 1283793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein C inhibitor: purification and proteinase reactivity.
    Pratt CW; Macik BG; Church FC
    Thromb Res; 1989 Mar; 53(6):595-602. PubMed ID: 2544038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
    Marlar RA; Kressin DC; Madden RM
    Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein.
    Laurell M; Stenflo J
    Thromb Haemost; 1989 Nov; 62(3):885-91. PubMed ID: 2556811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of protein C inhibitor activity.
    Neese LL; Pratt CW; Church FC
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):737-46. PubMed ID: 7532447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.
    España F; Gilabert J; Estellés A; Romeu A; Aznar J; Cabo A
    Thromb Res; 1991 Nov; 64(3):309-20. PubMed ID: 1725227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine plasma protein C inhibitor with structural and functional homologous properties to human plasma protein C inhibitor.
    Suzuki K; Kusumoto H; Nishioka J; Komiyama Y
    J Biochem; 1990 Mar; 107(3):381-8. PubMed ID: 2160449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator.
    Hayashi T; Nishioka J; Nakagawa N; Kamada H; Gabazza EC; Kobayashi T; Hattori A; Suzuki K
    J Thromb Haemost; 2007 Jul; 5(7):1477-85. PubMed ID: 17456194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.